ClinConnect ClinConnect Logo
Search / Trial NCT06057792

Elastography Changes in Cesarean Scar After Negative Pulsed Pressure Treatment

Launched by UNIVERSIDAD DE GRANADA · Sep 25, 2023

Trial Information

Current as of August 27, 2025

Not yet recruiting

Keywords

Elastography Cesarean Adherences Negative Pulsed Pressure

ClinConnect Summary

This clinical trial is studying how a special treatment called pulsed negative pressure can help improve the elasticity and overall condition of cesarean scars. The goal is to see if this treatment can stimulate the body’s natural healing response, making the scar tissue more flexible and less thick. The changes in the scars will be measured using a type of ultrasound called elastography, which helps to assess the elasticity of the tissue.

To be eligible for this trial, participants should be women aged 18 to 60 who have had a cesarean section and have a scar that is at least six months old but less than two years old. They should also have a scar that looks thick and may be causing some restrictions in the surrounding tissue. However, certain conditions may exclude individuals from participating, such as neurological issues or specific skin conditions like keloids. If you join the trial, you can expect to undergo treatment and follow-up assessments to evaluate how your scar is responding to the therapy.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Participants aged between 18 and 60 years
  • Who have undergone cesarean section surgery and therefore have a scar, lasting more than six months and less than 2 years.
  • Patients who present a post-cesarean section scar with a fibrotic appearance and possible surrounding fascial restrictions.
  • Exclusion Criteria:
  • Patients who present any neurological, inflammatory or orthopedic injury that prevents or alters balance, listening, vision or the cognitive abilities necessary to be able to answer appropriate questions or take questionnaires.
  • Patients who present keloids in the scar.
  • * Patients who have contraindications to be treated with a 448kHz radiofrequency device such as:
  • to. pregnant women b. Subjects with any type of electronic implants. c. Subjects presenting with thrombophlebitis

About Universidad De Granada

The Universidad de Granada is a prestigious academic institution in Spain, renowned for its commitment to research and innovation in the medical and health sciences. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide range of clinical trials designed to advance medical knowledge and improve patient care. Its dedicated team of researchers and clinicians work closely to ensure the ethical conduct and scientific rigor of all trials, contributing to the advancement of evidence-based medicine. The Universidad de Granada is dedicated to fostering an environment that promotes excellence in research, ultimately aiming to translate findings into clinical practice for the benefit of society.

Locations

Málaga, , Spain

Málaga, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported